News related to Cialis (Tadalafil) and/or conditions it is approved for
AMA Adopts Endocrine Society Resolution Opposing Medicare's Proposal To Eliminate Payments For Specialists
Source: Endocrinology News From Medical News Today [2009.11.11]
The American Medical Association's (AMA) House of Delegates adopted a resolution opposing all public and private payer efforts to eliminate physician consultation services. Physicians providing inpatient and outpatient consultation services play a crucial role in diagnosing and caring for patients with complex medical conditions.
Bay IVF Specialists To Restrict Number Of Embryos Transferred
Source: Fertility News From Medical News Today [2009.11.10]
As part of a nationwide effort to reduce unnecessary multiple births resulting from fertility treatment, the Reproductive Science Center of the San Francisco Bay Area (RSC) has embraced revised guidelines issued this October by the American Society for Reproductive Medicine (ASRM) intended to limit the number of embryos that should be transferred during in vitro fertilization (IVF) procedures.
Symposium Raises Awareness Of Specialists And Pediatricians About GI Disorders In Autism And Identifies Critical Areas For Further Study
Source: Autism News From Medical News Today [2009.11.02]
Autism Speaks, the American Academy of Pediatrics (AAP) and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) will host one of the largest gatherings of researchers, clinicians and pediatric specialists to better understand the gastrointestinal (GI) problems in children with autism spectrum disorders (ASDs).
New Use for Active Ingredient of Cialis
Source: MedicineNet Pulmonary Hypertension Specialty [2009.06.01]
Title: New Use for Active Ingredient of Cialis
Category: Health News
Created: 6/1/2009
Last Editorial Review: 6/1/2009
Tadalafil (Cialis) In The Treatment Of Erectile Dysfunction
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.05.30]
UroToday.com - This updated review of tadalafil (Cialis), one of the three available phosphodiesterase type 5 (PDE5) inhibitors that revolutionized the treatment of erectile dysfunction (ED), analyzes its latest clinical studies. Tadalafil's most unique and identifying characteristic is its long half-life of 17.5 hours, compared with 4 hours for sildenafil (Viagra) and vardenafil (Levitra).
Patients Win With Immediate Avastin Payment Reversal
Source: Eye Health / Blindness News From Medical News Today [2009.11.20]
Following efforts by the American Academy of Ophthalmology with the help of the American Society of Retina Specialists, the Macula Society, the Retina Society and Congressional allies, the Center for Medicare and Medicaid Services (CMS) said that it will retract an Oct. 1 payment policy for small doses of Avastin. Avastin, a cancer drug, is used in smaller doses to treat eye diseases such as age-related macular degeneration (AMD).
Thanks, But No Thanks: Avoiding Food Poisoning At Thanksgiving
Source: Nutrition / Diet News From Medical News Today [2009.11.20]
Thanksgiving is an opportunity to share a meal with loved ones, but it is also a time when small mistakes in the kitchen can lead to foodborne illness. Dr. Ben Chapman, food safety specialist and assistant professor of food science at North Carolina State University, can offer suggestions to ensure your Thanksgiving meal is a safe one. The U.S.
ImmuPharma PLC: Encouraging Final Phase IIb Results Seen With LUPUZOR™ In Systemic Lupus Erythematosus
Source: Lupus News From Medical News Today [2009.11.19]
ImmuPharma PLC (LSE:IMM) the specialist discovery and development pharmaceutical company is pleased to announce the final results from a Phase IIb trial of LUPUZOR™ in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor™ administered at 200 mcg once-a-month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care.
Maney Publishing Acquires Audiology Titles From Wiley-Blackwell
Source: Ear, Nose and Throat News From Medical News Today [2009.11.15]
Maney Publishing is pleased to announce the purchase of two quarterly journals from John Wiley & Sons, Ltd: Cochlear Implants International and Deafness & Education International, which together establish a decisive publishing commitment to the clinical treatment and education of the deaf. The acquisition also reflects Maney's continuing involvement and expertise in publishing for specialist societies and professional organisations.
New York Plastic Surgeon Eases Common Fear Of Rhinoplasty Surgery By Eliminating Traditional Packing And Painful Removal
Source: Cosmetic Medicine / Plastic Surgery News From Medical News Today [2009.11.11]
Dr. Oleh Slupchynskyj, Director of The Aesthetic Institute of New York and New Jersey, has revolutionized the rhinoplasty procedure by eliminating traditional packing and subsequent painful removal. The pain associated with the post-operative removal of nasal packing is a well-known and commonly cited fear among rhinoplasty candidates. Slupchynskyj, a rhinoplasty specialist, has alleviated this fear by utilizing recent advancements in packing material.
Hearing Study Focuses On AIDS Patients
Source: Hearing / Deafness News From Medical News Today [2009.11.05]
Specialists in HIV and in hearing at the University of Rochester Medical Center are teaming up to measure the hearing of people with AIDS. The five-year study is believed to be the first large study of its kind testing the hearing of people with HIV/AIDS and comparing the results with those from people without HIV. The new effort, supported by a $1.
Health Care Jobs Plentiful But Tough To Get
Source: Medical Students / Training News From Medical News Today [2009.11.05]
While health care jobs are plentiful, "getting one is hard work," The Associated Press/The News-Sentinel reports. "Many people who have lost jobs to the recession may find a cure for unemployment in the health care field," and the demand for nurses, specialists and technicians is strong.
NHS Still Failing Lung Cancer Patients Say Experts, UK
Source: Lung Cancer News From Medical News Today [2009.11.04]
The NHS is still failing lung cancer patients, according to the results of the first national review of lung cancer services, published this Monday.1 Despite headway in UK lung cancer prevention, disease awareness and screening, key areas such as diagnosis, treatment rates and access to specialists are still 'woefully inadequate' say the UK's leading lung cancer experts.
News From The Annals Of Internal Medicine, Nov. 3, 2009
Source: Arthritis / Rheumatology News From Medical News Today [2009.11.03]
Early Releases 1. Report Questions Whether Family Health History Disclosure Improves Clinical Decision Making Systematic collection of family history is a potentially important step in personalizing healthcare. Family health history can reveal important information about a patient, and may prompt specialist investigation or positive lifestyle changes.
Stop Seeing Red By Looking Through Blue-Tinted Lenses, UK
Source: Dyslexia News From Medical News Today [2009.07.21]
As the UK enters a summer of discontent, one company has a vision to make the outlook decidedly brighter - by looking at life through blue-tinted spectacles. Wearing blue lenses has a calming effect, can reduce appetite and even help with dyslexia. Now online optics specialists Ciliary Blue are offering blue views to cheer up a nation blighted by recession, redundancies and bank balances in the red.
Bercow Review: Speech, Language & Communication Services For Children And Young People Must Improve, UK
Source: Dyslexia News From Medical News Today [2008.03.21]
Children and young people must be given the support they need to overcome speech, language and communications difficulties so they enjoy the same opportunities to learn, socialise and succeed as anyone else, according to an interim report presented by John Bercow MP to the Secretaries of State for Health and for Children, Schools and Families.
Effects Of Once-Daily Tadalafil On Erectile Function In Men With Erectile Dysfunction And Signs And Symptoms Of Benign Prostatic Hyperplasia
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.07.12]
UroToday.com - Men with benign prostatic hyperplasia (BPH) often suffer from lower urinary tract symptoms (LUTS; BPH-LUTS) such as urinary frequency, urgency, intermittency, nocturia, straining, incomplete emptying, or weak urinary stream. BPH-LUTS and erectile dysfunction (ED), both highly prevalent conditions in aging men, are frequently associated in the same men, may have common pathophysiological mechanisms, and contribute negatively to quality of life.
Study Reported Tadalafil Taken Once Daily Improved Erectile Function In Men With ED And Sexual Quality Of Life In Couples
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.05.07]
Eli Lilly and Company (NYSE: LLY) announced results from a double-blind, placebo-controlled study which showed that tadalafil 5 mg dose taken once daily was generally well-tolerated, improved erectile function for men with erectile dysfunction (ED) and reported improvement in the sexual quality of life scores for men and their female partners.
|
